Brand hub

Teva Pharmaceuticals, Inc. Recalls

4 recalls found for Teva Pharmaceuticals, Inc.. Check current safety alerts and related brands before using affected products.

Active recalls: 4
Pages: 1

HIGH

FDA DRUG

Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled syringe containing 2 mL of diluent, one...

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

Apr 24, 2026

OCTREOTIDE ACETATE

Lack of

Health & Personal Care

HIGH

FDA DRUG

Teva Octreotide Acetate Injectable Suspension Recall 21,930 Cartons Over Sterility Risk (2026)

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

Mar 17, 2026

OCTREOTIDE ACETATE

Lack of

Health & Personal Care

HIGH

FDA DRUG

Teva Octreotide Acetate Injectable Suspension Recall 19,869 Cartons Nationwide (2026)

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

Mar 17, 2026

OCTREOTIDE ACETATE

Lack of

Health & Personal Care

HIGH

FDA DRUG

Teva Octreotide Acetate Injectable Suspension Recall Expanded in 2026 for Sterility Concerns

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

Mar 17, 2026

OCTREOTIDE ACETATE

Lack of

Brand Statistics

Total Recalls

Pages

Related Brands

OCTREOTIDE ACETATE